This site is intended for heath plan professionals in Canada.

This site is intended for health plan professionals in Canada.

U.S. professionals should visit ManagedCareCGM.com

Continuous Glucose Monitoring

Continuous Glucose Monitoring - CGM

Insights & Education for Health Benefit Plan Professionals in Canada

Search

Using CGM to Aid in Virtual Care and Improve Diabetes Management

Unveiling the Latest Evidence:
CGM’s Evolving Impact on Diabetes Care

CGM Improves Glycemic Control and
Reduces CVD Risk in Non-Insulin-Treated T2D

Next-Generation Dexcom G7 CGM
System Approved by Health Canada

ADA 2023 Highlights:
The Clinical and Economic Value of CGM

Watch Now

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program – Diabetes Technology & Therapeutics – 2018